Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa

BACKGROUND: In South Africa, the first HBV vaccine dose is administered at age 6 weeks, leaving a potential window for vertical transmission. Insights into HBV seroprevalence in the vulnerable HIV-infected group are important to drive improvements in surveillance, treatment and prevention. OBJECTIVE...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Virol
Päätekijät: Jooste, Pieter, van Zyl, Anriette, Adland, Emily, Daniels, Samantha, Hattingh, Louise, Brits, Alethea, Wareing, Susan, Goedhals, Dominique, Jeffery, Katie, Andersson, Monique, Goulder, Philip, Matthews, Philippa C.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier Science 2016
Aiheet:
Short Communication
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5142290/
https://ncbi.nlm.nih.gov/pubmed/27838494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2016.10.017
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia